SCHEMBL14715852

SCHEMBL14715852

O=C(O)[C@H](O)[C@@H](O)C(=O)Nc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.57
MAPT P10636 7/20 0.56
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
ALDH1A1 P00352 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
RXFP1 Q9HBX9 1/20 0.56
HPGD P15428 1/20 0.56
HTT P42858 1/20 0.56
TP53 P04637 1/20 0.52
EPHX1 P07099 1/20 0.52
TSHR P16473 1/20 0.52
EPHX2 P34913 1/20 0.52
CDK9 P50750 1/20 0.52
CLK4 Q9HAZ1 1/20 0.52
GAA P10253 4/20 0.52
ATM Q13315 3/20 0.52
LMNA P02545 2/20 0.52
HSP90AA1 P07900 2/20 0.50
NPC1 O15118 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1735243 1.00 POLB (0.57) POLBMAPTMEN1KMT2AALDH1A1
SCHEMBL1736418 1.00 POLB (0.57) POLBMAPTMEN1KMT2AALDH1A1
SCHEMBL18137202 0.84 KMT2A (0.54) POLBMAPTMEN1KMT2AALDH1A1
SCHEMBL701232 0.84 KMT2A (0.54) POLBMAPTMEN1KMT2AALDH1A1
SCHEMBL699996 0.82 MAPT (0.58) POLBMAPTMEN1KMT2AALDH1A1
SCHEMBL7827059 0.82 KMT2A (0.50) POLBMAPTMEN1KMT2AALDH1A1
SCHEMBL4086777 0.82 MAPT (0.58) POLBMAPTMEN1KMT2AALDH1A1
Diphenylamine SCHEMBL21145177 0.82 HSD17B10 (0.60) POLBMAPTMEN1KMT2AALDH1A1
Diphenylamine SCHEMBL21145179 0.82 HSD17B10 (0.60) POLBMAPTMEN1KMT2AALDH1A1
SCHEMBL11050303 0.81 POLB (0.59) POLBMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760750-B1 Process for preparing levoketoconazole NURAY CHEMICALS PRIVATE LIMITED (IN) 2023-09-19 US claimed
US-12384757-B2 Methods of synthesizing substituted pyridinone-pyridinyl compounds ACLARIS THERAPEUTICS, INC. (US) 2025-08-12 US disclosed
US-20240043398-A1 METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS ACLARIS THERAPEUTICS, INC. 2024-02-08 US disclosed
US-11767309-B2 Methods of synthesizing substituted pyridinone-pyridinyl compounds ACLARIS THERAPEUTICS, INC. (US) 2023-09-26 US disclosed
US-11760750-B1 Process for preparing levoketoconazole NURAY CHEMICALS PRIVATE LIMITED (IN) 2023-09-19 US disclosed
US-20230202999-A9 METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS ACLARIS THERAPEUTICS, INC. 2023-06-29 US disclosed
US-20220235025-A1 METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS ACLARIS THERAPEUTICS INC (US) 2022-07-28 US disclosed
EP-2565245-B1 Moisture-proof material NITTO DENKO CORP (JP) 2018-07-25 EP disclosed
US-9546303-B2 Moisture-proof material NITTO DENKO CORPORATION (JP) 2017-01-17 US disclosed
US-20130337261-A1 MOISTURE-PROOF MATERIAL NITTO DENKO CORPORATION (JP) 2013-12-19 US disclosed
EP-2666836-A2 Moisture-proof material Nitto Denko Corporation (JP) 2013-11-27 EP disclosed
EP-2565245-A2 Moisture-proof material NITTO DENKO CORPORATION (JP) 2013-03-06 EP disclosed
US-20130052461-A1 MOISTURE-PROOF MATERIAL NITTO DENKO CORPORATION (JP) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767309-B2 Methods of synthesizing substituted pyridinone-pyridinyl compounds PIR, PUM1, ZRANB2 POLB 1068/4885MAPT 3296/4885MEN1 779/4885
US-12384757-B2 Methods of synthesizing substituted pyridinone-pyridinyl compounds PIR, PUM1, ZRANB2 POLB 1068/4885MAPT 3296/4885MEN1 779/4885
US-20220235025-A1 METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS PIR, PUM1, ZRANB2 POLB 1068/4885MAPT 3296/4885MEN1 779/4885
US-20240043398-A1 METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS PIR, PUM1, ZRANB2 POLB 1068/4885MAPT 3296/4885MEN1 779/4885
US-20230202999-A9 METHODS OF SYNTHESIZING SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS PIR, PUM1, ZRANB2 POLB 1068/4885MAPT 3296/4885MEN1 779/4885
US-11760750-B1 Process for preparing levoketoconazole KHK, KYAT3, PLK3 POLB 1887/4885MAPT 1668/4885MEN1 2073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.